James E. Polli, PhD

Titles

Professor of Pharmaceutical Sciences

Ralph F. Shangraw/Noxell Endowed Chair in Industrial Pharmacy and Pharmaceutics

Director, MS in Regulatory Science Program

School Affiliation

School of Pharmacy

Specialties

  • Regulatory Affairs
  • Bioequivalence of Brand and Generic Drugs

About

Dr. Polli’s research focus is oral drug absorption. His two main research interests are 1) maximizing oral bioavailability through formulation and chemical approaches and 2) developing public quality standards for oral dosage forms. He has served as advisor to 24 Ph.D. graduates. He is co-Director of the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) and the Center for Research on Complex Generics (CRCG), each an FDA-funded collaborative agreement with the Agency. He is Director of the online MS in Regulatory Science program. He is a fellow of the American Association for Pharmaceutical Scientists (AAPS) and served as an editor of its flagship journal Pharmaceutical Research for 12 years. He was the recipient of the 2022 AAPS Global Leadership Award and 2021 TOPRA Education Award.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: Ensuring Access and Equity in Health Care   Research and Innovation  

This information was last updated January 9, 2024.